Phibro Animal Health CorporationPAHCNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank54
3Y CAGR-61.4%
5Y CAGR-7.1%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
-61.4%/yr
Quarterly compound
5Y CAGR
-7.1%/yr
Recent deceleration
Percentile
P54
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 4.62% |
| Q3 2025 | 54.76% |
| Q2 2025 | -19.23% |
| Q1 2025 | 550.00% |
| Q4 2024 | -52.94% |
| Q3 2024 | 813.98% |
| Q2 2024 | -91.14% |
| Q1 2024 | 600.00% |
| Q4 2023 | 115.00% |
| Q3 2023 | -171.43% |
| Q2 2023 | 12.00% |
| Q1 2023 | 38.89% |
| Q4 2022 | 80.00% |
| Q3 2022 | -44.44% |
| Q2 2022 | -59.09% |
| Q1 2022 | 2.33% |
| Q4 2021 | 168.75% |
| Q3 2021 | -61.90% |
| Q2 2021 | 40.00% |
| Q1 2021 | -6.25% |
| Q4 2020 | 6.67% |
| Q3 2020 | 114.29% |
| Q2 2020 | -57.58% |
| Q1 2020 | 13.79% |
| Q4 2019 | 383.33% |
| Q3 2019 | -72.73% |
| Q2 2019 | -40.54% |
| Q1 2019 | 0.00% |
| Q4 2018 | -7.50% |
| Q3 2018 | -27.27% |
| Q2 2018 | 12.24% |
| Q1 2018 | 188.24% |
| Q4 2017 | -57.50% |
| Q3 2017 | 2.56% |
| Q2 2017 | -35.00% |
| Q1 2017 | 76.47% |
| Q4 2016 | 9.68% |
| Q3 2016 | -20.51% |
| Q2 2016 | -17.02% |
| Q1 2016 | -38.96% |